Clinical Trials in Maryland

Showing 20281-20300 of 23,284 trials

Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3

NCT00056862

This study will examine the effectiveness of low-dose peginterferon and ribavirin therapy for certain patients with chronic hepatitis C-a liver disease that, in some patients, can progress to cirrhosis of the liver, liver cancer, and liver failure.

Hepatitis C

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)58 participantsStarted Mar 2003

Bethesda, Maryland, United States

TERMINATEDPhase 317 miles

Phase 3 Randomized Study of Telcyta + Doxorubicin Versus Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer

NCT00350948

The purpose of this research study is to determine if Telcyta® given in combination with liposomal doxorubicin is more effective than liposomal doxorubicin alone in treating women who have recurrent ovarian epithelial cancer, fallopian tube cancer or primary peritoneal cancer that is refractory or resistant to platinum chemotherapy.

Ovarian Neoplasms

Telik244 participantsStarted May 2006

Casa Grande, Arizona, United States • Little Rock, Arkansas, United States • Little Rock, Arkansas, United States +68 more locations

Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3

Phase 3 Randomized Study of Telcyta + Doxorubicin Versus Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer

Find Trials by Condition in Maryland

Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer

Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy

A Study of Aripiprazole in Patients With Major Depressive Disorder

Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)

Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology

Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)

Efficacy and Safety Study With Visonac Photodynamic Therapy (PDT)

Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding

Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel

Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)

VI-1121 for the Treatment Alzheimer's Disease

Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine

Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations

Mindfulness Meditation in Bone Marrow Transplantation

Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer

Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma